IBBQ holdings — Invesco Nasdaq Biotechnology ETF
Invesco Nasdaq Biotechnology ETF (IBBQ) held 261 positions with net assets of $67.4M as of May 31, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 56.6% of the fund, led by Invesco Private Prime Fund, GILD, VRTX.
IBBQ top holdings
- Invesco Private Prime Fund — 14.20% ($9.57M)
- GILD Gilead Sciences, Inc. — 7.39% ($4.98M)
- VRTX Vertex Pharmaceuticals Inc. — 7.38% ($4.97M)
- AMGN Amgen Inc. — 7.10% ($4.79M)
- Invesco Private Government Fund — 5.48% ($3.69M)
- REGN Regeneron Pharmaceuticals, Inc. — 5.08% ($3.42M)
- ALNY Alnylam Pharmaceuticals, Inc. — 3.19% ($2.15M)
- RVMD Revolution Medicines, Inc. — 2.48% ($1.67M)
- BIIB Biogen Inc. — 2.29% ($1.54M)
- ILMN Illumina, Inc. — 1.98% ($1.34M)
- UTHR United Therapeutics Corp. — 1.94% ($1.31M)
- RPRX Royalty Pharma PLC — 1.90% ($1.28M)
- ARGX argenx SE — 1.89% ($1.27M)
- INSM Insmed Inc. — 1.83% ($1.24M)
- ROIV Roivant Sciences Ltd. — 1.71% ($1.15M)
- INCY Incyte Corp. — 1.53% ($1.03M)
- VTRS Viatris Inc. — 1.49% ($1.00M)
- MRNA Moderna, Inc. — 1.48% ($999K)
- GH Guardant Health, Inc. — 1.35% ($912K)
- NBIX Neurocrine Biosciences, Inc. — 1.26% ($852K)
- JAZZ Jazz Pharmaceuticals PLC — 1.16% ($780K)
- ASND Ascendis Pharma A/S — 1.10% ($740K)
- SMMT Summit Therapeutics Inc. — 1.08% ($729K)
- EXEL Exelixis, Inc. — 1.04% ($703K)
- BBIO BridgeBio Pharma, Inc. — 1.02% ($689K)
What are IBBQ's top 10 holdings?
Invesco Private Prime Fund (14.2%), GILD (7.4%), VRTX (7.4%), AMGN (7.1%), Invesco Private Government Fund (5.5%), REGN (5.1%), ALNY (3.2%), RVMD (2.5%), BIIB (2.3%), ILMN (2.0%).
How many stocks are in IBBQ?
Invesco Nasdaq Biotechnology ETF reported 261 holdings as of May 31, 2026.